Current
93.52 €
+0.36% today
Start price
68.23 €
Target price
75.58 €
+1.3% to target
End price
74.60 €
Performance (%)
+9.34%
Return to target
+1.3%
Confidence
50%
Time horizon
2025-11-27
Performance since start
How it ranks
- #70 Rank 70 of 143 by performance
- 69 ratings for this instrument performed better
- 42 other running ratings for this instrument
Summary
This prediction ended on 28.11.25 with a price of €74.60. With a performance of 9.34%, the BUY prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp. closed with a slight gain. Royal_Bank_of_Canada has 50% into this prediction
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.